Caris Life Sciences (CAI) Other Non-Current Assets (2024 - 2026)

Caris Life Sciences has reported Other Non-Current Assets for 3 years, with the latest figure at $56.7 million in Q2 2026.

• On a quarterly basis, Other Non-Current Assets rose 38.1% year-over-year to $56.7 million in Q2 2026; TTM through Jun 2026 was $56.7 million, a 38.1% increase from a year earlier, with the FY2025 full-year figure at $45.3 million, up 11.03% from the prior year.
• Other Non-Current Assets was $56.7 million for Q2 2026 at Caris Life Sciences, up from $46.2 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $56.7 million in Q2 2026, with the low at $4.1 million in Q1 2025.
• Average Other Non-Current Assets over 3 years is $40.2 million, with a median of $45.3 million recorded in 2025.
• The sharpest annual moves came in 2025 and 2026: Other Non-Current Assets rose 11.03% in 2025, then surged 1029.74% in 2026.
• Over 3 years, Other Non-Current Assets stood at $40.8 million in 2024, then gained by 11.03% to $45.3 million in 2025, then increased by 25.1% to $56.7 million in 2026.
• The last three Other Non-Current Assets figures came in at $56.7 million (Q2 2026), $46.2 million (Q1 2026), and $45.3 million (Q4 2025), per Business Quant data.